Clinical
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS
2
Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo
3
PMOS Awareness Month: Watch our expert panel discussion on PMOS
4
Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal
5